Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;25(1):90-102.
doi: 10.1016/j.gim.2022.09.010. Epub 2022 Oct 31.

Brain monoamine vesicular transport disease caused by homozygous SLC18A2 variants: A study in 42 affected individuals

Ken Saida  1 Reza Maroofian  2 Toru Sengoku  3 Tadahiro Mitani  4 Alistair T Pagnamenta  5 Dana Marafi  6 Maha S Zaki  7 Thomas J O'Brien  8 Ehsan Ghayoor Karimiani  9 Rauan Kaiyrzhanov  2 Marina Takizawa  1 Sachiko Ohori  1 Huey Yin Leong  10 Gulsen Akay  4 Hamid Galehdari  11 Mina Zamani  11 Ratna Romy  12 Christopher J Carroll  12 Mehran Beiraghi Toosi  13 Farah Ashrafzadeh  14 Shima Imannezhad  15 Hadis Malek  16 Najmeh Ahangari  16 Hoda Tomoum  17 Vykuntaraju K Gowda  18 Varunvenkat M Srinivasan  18 David Murphy  19 Natalia Dominik  2 Hasnaa M Elbendary  7 Karima Rafat  7 Sanem Yilmaz  20 Seda Kanmaz  20 Mine Serin  20 Deepa Krishnakumar  21 Alice Gardham  21 Anna Maw  22 Tekki Sreenivasa Rao  23 Sarah Alsubhi  24 Myriam Srour  25 Daniela Buhas  26 Tamison Jewett  27 Rachel E Goldberg  27 Hanan Shamseldin  28 Eirik Frengen  29 Doriana Misceo  29 Petter Strømme  30 José Ricardo Magliocco Ceroni  31 Chong Ae Kim  31 Gozde Yesil  32 Esma Sengenc  33 Serhat Guler  34 Mariam Hull  35 Mered Parnes  35 Dilek Aktas  36 Banu Anlar  37 Yavuz Bayram  38 Davut Pehlivan  39 Jennifer E Posey  4 Shahryar Alavi  40 Seyed Ali Madani Manshadi  41 Hamad Alzaidan  42 Mohammad Al-Owain  42 Lama Alabdi  43 Ferdous Abdulwahab  28 Futoshi Sekiguchi  1 Kohei Hamanaka  1 Atsushi Fujita  1 Yuri Uchiyama  44 Takeshi Mizuguchi  1 Satoko Miyatake  45 Noriko Miyake  46 Reem M Elshafie  47 Kamran Salayev  48 Ulviyya Guliyeva  49 Fowzan S Alkuraya  50 Joseph G Gleeson  51 Kristin G Monaghan  52 Katherine G Langley  52 Hui Yang  52 Mahsa Motavaf  53 Saeid Safari  53 Mozhgan Alipour  54 Kazuhiro Ogata  3 André E X Brown  8 James R Lupski  55 Henry Houlden  2 Naomichi Matsumoto  56
Affiliations
Free article

Brain monoamine vesicular transport disease caused by homozygous SLC18A2 variants: A study in 42 affected individuals

Ken Saida et al. Genet Med. 2023 Jan.
Free article

Abstract

Purpose: Brain monoamine vesicular transport disease is an infantile-onset movement disorder that mimics cerebral palsy. In 2013, the homozygous SLC18A2 variant, p.Pro387Leu, was first reported as a cause of this rare disorder, and dopamine agonists were efficient for treating affected individuals from a single large family. To date, only 6 variants have been reported. In this study, we evaluated genotype-phenotype correlations in individuals with biallelic SLC18A2 variants.

Methods: A total of 42 affected individuals with homozygous SLC18A2 variant alleles were identified. We evaluated genotype-phenotype correlations and the missense variants in the affected individuals based on the structural modeling of rat VMAT2 encoded by Slc18a2, with cytoplasm- and lumen-facing conformations. A Caenorhabditis elegans model was created for functional studies.

Results: A total of 19 homozygous SLC18A2 variants, including 3 recurrent variants, were identified using exome sequencing. The affected individuals typically showed global developmental delay, hypotonia, dystonia, oculogyric crisis, and autonomic nervous system involvement (temperature dysregulation/sweating, hypersalivation, and gastrointestinal dysmotility). Among the 58 affected individuals described to date, 16 (28%) died before the age of 13 years. Of the 17 patients with p.Pro237His, 9 died, whereas all 14 patients with p.Pro387Leu survived. Although a dopamine agonist mildly improved the disease symptoms in 18 of 21 patients (86%), some affected individuals with p.Ile43Phe and p.Pro387Leu showed milder phenotypes and presented prolonged survival even without treatment. The C. elegans model showed behavioral abnormalities.

Conclusion: These data expand the phenotypic and genotypic spectra of SLC18A2-related disorders.

Keywords: Brain monoamine vesicular transport disease; Dopamine agonist; Dystonia; SLC18A2; VMAT2.

PubMed Disclaimer

Publication types